Methamphetamine exposure during pregnancy: A meta-analysis of child developmental outcomes

Chelsea Kunkler1, Andrew J Lewis2, Renita Almeida1

  • 1School of Psychology, Murdoch University, Australia.

Insights

Prenatal methamphetamine exposure significantly impacts child development, affecting cognitive, language, and motor skills. Further research is needed to understand these developmental outcomes and develop interventions.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pediatrics

Background:

  • Maternal methamphetamine use during pregnancy poses risks to fetal development.
  • Understanding the long-term consequences of prenatal drug exposure is crucial for child health.
  • Existing research highlights potential neurodevelopmental deficits in exposed children.

Purpose of the Study:

  • To systematically review and synthesize findings on developmental outcomes in children with prenatal methamphetamine exposure.
  • To examine cognitive, language, motor, and neuroanatomical effects.
  • To identify gaps in knowledge and areas for future research.

Main Methods:

  • Systematic literature search of PSYCHINFO, Scopus, PubMed, and ERIC databases up to December 2020.
  • Inclusion of 38 articles focusing on children aged birth to 16 years.
  • Quality appraisal using the Newcastle Ottawa Quality Assessment Scale and meta-analysis of 14 studies.

Main Results:

  • Prenatal methamphetamine exposure is associated with altered brain microstructure and reduced subcortical volumes.
  • Meta-analysis revealed significant negative impacts on intellectual functioning (d=0.89), problem-solving (d=0.82), short-term memory (d=0.91), and language development (d=0.74).
  • Study limitations include small sample sizes, heterogeneity, and confounding factors, necessitating further investigation.

Conclusions:

  • Intrauterine methamphetamine exposure has a substantial adverse effect on multiple domains of child development.
  • There is a critical need for more rigorous studies, including intervention research, to inform prevention and harm reduction strategies.
  • Early identification and support are vital for children affected by prenatal methamphetamine exposure.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
319
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
471